Augustana Hcc Of Apple Valley | |
14650 Garrett Avenue, Apple Valley, Minnesota 55124 | |
(952) 236-2000 | |
Name | Augustana Hcc Of Apple Valley |
---|---|
Location | 14650 Garrett Avenue, Apple Valley, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 178 |
Occupancy Rate | 62.42% |
Medicare ID (CCN) | 245264 |
Legal Business Name | Augustana Health Care Center Of Apple Valley |
Ownership Type | Non Profit - Corporation |
NPI Number | 1790733483 |
Organization Name | AUGUSTANA HEALTH CARE CENTER OF APPLE VALLEY |
Address | 14650 Garrett Ave, Apple Valley, MN 55124 |
Phone Number | 952-236-2500 |
News Archive
Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.
Data from a new study presented today at the annual meeting of the European Association for the Study of Diabetes (EASD) shows that type 2 diabetes patients starting insulin treatment with once-daily injection of NovoMix® 30 (biphasic insulin aspart) achieve a significantly greater HbA1c reduction compared to patients starting with a daily injection of insulin glargine.
TEV-48125, a monoclonal anti-calcitonin-gene related peptide antibody, is well tolerated and effective in the prevention of high-frequency episodic migraine and chronic migraine, findings from two phase IIb studies show.
The 13th annual Bio-IT World Conference & Expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, today announced that it will debut a new disciplinary track focused on data security.
Historic new guidelines that will ensure women receive preventive health services at no additional cost were announced today by the U.S. Department of Health and Human Services (HHS).
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.
Data from a new study presented today at the annual meeting of the European Association for the Study of Diabetes (EASD) shows that type 2 diabetes patients starting insulin treatment with once-daily injection of NovoMix® 30 (biphasic insulin aspart) achieve a significantly greater HbA1c reduction compared to patients starting with a daily injection of insulin glargine.
TEV-48125, a monoclonal anti-calcitonin-gene related peptide antibody, is well tolerated and effective in the prevention of high-frequency episodic migraine and chronic migraine, findings from two phase IIb studies show.
The 13th annual Bio-IT World Conference & Expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, today announced that it will debut a new disciplinary track focused on data security.
Historic new guidelines that will ensure women receive preventive health services at no additional cost were announced today by the U.S. Department of Health and Human Services (HHS).
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $15500 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 8.04 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.73 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 62.18 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.18 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.09 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.95 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.28 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.93 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 6.17 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.08 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.86 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 21.31 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 5.94 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.97 | 95.98 |
Percentage of short-stay residents who made improvements in function | 90.53 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 66.53 | 82.93 |
News Archive
Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.
Data from a new study presented today at the annual meeting of the European Association for the Study of Diabetes (EASD) shows that type 2 diabetes patients starting insulin treatment with once-daily injection of NovoMix® 30 (biphasic insulin aspart) achieve a significantly greater HbA1c reduction compared to patients starting with a daily injection of insulin glargine.
TEV-48125, a monoclonal anti-calcitonin-gene related peptide antibody, is well tolerated and effective in the prevention of high-frequency episodic migraine and chronic migraine, findings from two phase IIb studies show.
The 13th annual Bio-IT World Conference & Expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, today announced that it will debut a new disciplinary track focused on data security.
Historic new guidelines that will ensure women receive preventive health services at no additional cost were announced today by the U.S. Department of Health and Human Services (HHS).
› Verified 2 days ago
Augustana Hcc Of Apple Valley Location: 14650 Garrett Avenue, Apple Valley, Minnesota 55124 Phone: (952) 236-2000 |